104 related articles for article (PubMed ID: 15465467)
1. Severe hypercalcaemia from secretion of parathyroid hormone-related peptide.
Barakat MT; Ashrafian H; Todd JF; Meeran K; Williams GR
Lancet Oncol; 2004 Oct; 5(10):633-5. PubMed ID: 15465467
[No Abstract] [Full Text] [Related]
2. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
3. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases.
Milanesi A; Yu R; Wolin EM
Pancreatology; 2013; 13(3):324-6. PubMed ID: 23719609
[TBL] [Abstract][Full Text] [Related]
4. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia.
Kanakis G; Kaltsas G; Granberg D; Grimelius L; Papaioannou D; Tsolakis AV; Öberg K
J Clin Endocrinol Metab; 2012 Apr; 97(4):E627-31. PubMed ID: 22319031
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcaemia induced by excessive parathyroid hormone secretion in a patient with a neuroendocrine tumour.
Vacher-Coponat H; Opris A; Denizot A; Dussol B; Berland Y
Nephrol Dial Transplant; 2005 Dec; 20(12):2832-5. PubMed ID: 16188904
[No Abstract] [Full Text] [Related]
6. Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour.
Teng J; Abell S; Hicks RJ; Hofman MS; Sachithanandan N; McKelvie P; MacIsaac RJ
Clin Endocrinol (Oxf); 2014 Dec; 81(6):940-2. PubMed ID: 24890549
[No Abstract] [Full Text] [Related]
7. Parathryoid hormone related peptide causing hypercalcaemia in a patient with hepatocellular carcinoma.
Sultan-e-Rome ; Sharif S; Shah AA
J Pak Med Assoc; 2013 Feb; 63(2):263-4. PubMed ID: 23894909
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
10. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein in pancreatic exocrine cancer associated with hypercalcaemia.
Bandyopadhyay P; Baksi S; Bandyopadhyay D; Patel CU
Int J Clin Pract; 2003 Mar; 57(2):140-2. PubMed ID: 12661799
[TBL] [Abstract][Full Text] [Related]
12. Clinical Analysis and Comprehensive Treatment of Nonfunctional Pancreatic Neuroendocrine Tumor With Liver Metastases: A Retrospective Single-Center Study.
Xu X; Han X; Liu L; Ji Y; Li J; Lou W
Pancreas; 2015 Aug; 44(6):995-6. PubMed ID: 26166471
[No Abstract] [Full Text] [Related]
13. Humoral hypercalcaemia of benignancy. A case report.
Herring R; Laji K
QJM; 2008 Apr; 101(4):329-30. PubMed ID: 18270225
[No Abstract] [Full Text] [Related]
14. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)--associated hypercalcemia of malignancy.
Clemens P; Gregor M; Lamberts R
Exp Clin Endocrinol Diabetes; 2001; 109(7):378-85. PubMed ID: 11573150
[TBL] [Abstract][Full Text] [Related]
15. An unusual case of hypercalcaemia.
Childs J; Rathur H; Norris A
Br J Hosp Med (Lond); 2010 Jul; 71(7):412-3. PubMed ID: 20631661
[No Abstract] [Full Text] [Related]
16. Steve Jobs's cancer. Pancreatic neuroendocrine tumors are becoming more common (the bad news) and also more treatable (the good news).
Harv Health Lett; 2012 Jan; 37(3):1-3. PubMed ID: 22400158
[No Abstract] [Full Text] [Related]
17. Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1).
Burgess JR; Wilkinson S; Lowenthal RM
Aust N Z J Med; 2000 Apr; 30(2):280-1. PubMed ID: 10833127
[No Abstract] [Full Text] [Related]
18. Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.
Abraham P; Ralston SH; Hewison M; Fraser WD; Bevan JS
Postgrad Med J; 2002 Dec; 78(926):752-3. PubMed ID: 12509695
[TBL] [Abstract][Full Text] [Related]
19. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
20. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
